Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
USANA Health Sciences is a packaged foods business based in the US. USANA Health Sciences shares (USNA) are listed on the NYSE and all prices are listed in US Dollars. USANA Health Sciences employs 1,978 staff and has a trailing 12-month revenue of around $1 billion.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $58.44 |
|---|---|
| 52-week range | $48.61 - $96.02 |
| 50-day moving average | $54.06 |
| 200-day moving average | $63.94 |
| Wall St. target price | $49.00 |
| PE ratio | 14.3478 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $3.91 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $58.44 from 2023-01-31
| 1 week (2023-01-24) | 4.60% |
|---|---|
| 1 month (2022-12-28) | N/A |
| 3 months (2022-10-31) | 11.29% |
| 6 months (2022-07-28) | -16.70% |
| 1 year (2022-02-01) | -39.02% |
|---|---|
| 2 years (2021-02-01) | -28.57% |
| 3 years (2020-01-31) | 61.7 |
| 5 years (2018-02-01) | 74.95 |
Valuing USANA Health Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of USANA Health Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
USANA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, USANA Health Sciences shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
USANA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0695. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into USANA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
USANA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $130 million.
The EBITDA is a measure of a USANA Health Sciences's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1 billion |
|---|---|
| Operating margin TTM | 11.23% |
| Gross profit TTM | $968.6 million |
| Return on assets TTM | 12.84% |
| Return on equity TTM | 18.98% |
| Profit margin | 7.41% |
| Book value | $21.41 |
| Market capitalisation | $1.1 billion |
TTM: trailing 12 months
We're not expecting USANA Health Sciences to pay a dividend over the next 12 months.
USANA Health Sciences's shares were split on a 2:1 basis on 22 November 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your USANA Health Sciences shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for USANA Health Sciences shares which in turn could have impacted USANA Health Sciences's share price.
Over the last 12 months, USANA Health Sciences's shares have ranged in value from as little as $48.61 up to $96.02. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while USANA Health Sciences's is 0.7157. This would suggest that USANA Health Sciences's shares are less volatile than average (for this exchange).
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.